The university hospital of Heidelberg is one of the largest medical centers in the Federal Republic of Germany
The Latest Bing News on:
University Hospital Heidelberg Research
- Scientists develop a marker for therapy response in acute myeloid leukemia
Doctors and scientists from the German Cancer Research Center, the Heidelberg Stem Cell Institute HI-STEM and Heidelberg University Hospital have now developed a marker for therapy response ...
- Marker for therapy response in acute myeloid leukemia (AML) identified
Doctors and scientists from the German Cancer Research Center, the Heidelberg Stem Cell Institute HI-STEM* and Heidelberg University Hospital have now developed a marker for therapy response ...
- Gut microbiome influences how lymphoma patients respond to CAR T therapy
In a new study published in Nature Medicine, Moffitt Cancer Center physician-scientists, in collaboration with four cancer centers in the United States and Germany, reveal how microorganisms in the ...
- HMC Hosts 4Th Annual Doha-Heidelberg Rare Diseases Conference
Doha: The fourth edition of the successful Doha–Heidelberg research conference on Rare Diseases was recently hosted by Hamad Medical Corporation (HMC) and Heidelberg University Hospital (HUH) at ...
- HMC and Heidelberg University Hospital discuss latest rarediseases diagnosis techniques
and Heidelberg University Hospital (HUH) recently hosted the fourth edition of the successful Doha–Heidelberg research conference on Rare Diseases at the Itqan Simulation and Clinical Innovation ...
The Latest Bing News on:
University Hospital Heidelberg Discovery
- Drug Discovery & Development
The Master of Science degree program in Drug Discovery & Development (DDD) offers students the opportunity to understand, evaluate and engage with the entire process of drug discovery and development.
- University Hospital-Augusta
Scores are based on surveys taken from this hospital’s inpatients after they were discharged inquiring about different aspects of their stay. The scores are not used in the Best Hospitals rankings.
- Marker for therapy response in acute myeloid leukemia identified
Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug combination does not work.
- Marker for therapy response in acute myeloid leukemia (AML) identified
Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug combination does not work.
- HMC and Heidelberg University Hospital discuss latest rarediseases diagnosis techniques
Hamad Medical Corporation (HMC) and Heidelberg University Hospital (HUH) recently hosted the fourth edition of the successful Doha–Heidelberg research conference on Rare Diseases at the Itqan ...
